How Are Renal Therapies Chosen? Medical Care, Dialysis Planning and Transplant Evaluation

Key Takeaways
- CKD is defined by kidney damage or reduced function lasting more than three months, so a single abnormal test is repeated before any diagnosis or treatment change is made.
- The CDC estimates as many as 9 in 10 US adults with chronic kidney disease do not know they have it, which is why screening is tied to risk factors such as diabetes and high blood pressure rather than to symptoms.
- ACE inhibitors, angiotensin receptor blockers and SGLT2 inhibitors all slow kidney decline through the same mechanism: lowering pressure and protein leakage inside the glomeruli.
- In-center hemodialysis typically means three sessions a week of about four hours, while peritoneal dialysis is done daily at home either by hand or overnight by machine.
- A fistula for hemodialysis needs weeks to months to strengthen before use, which is the practical reason planning conversations begin at stage 4 rather than stage 5.
- Conservative kidney management is an active treatment plan focused on symptoms and quality of life, recognized in guidelines as a legitimate choice rather than the absence of care.
Kidney disease treatment is chosen in stages, guided by how much filtering function remains, how fast it is falling, the underlying cause and a person's own priorities. Early care protects remaining function with blood pressure, blood sugar, medicines and diet. If function falls to kidney failure, the team plans dialysis, evaluates transplant suitability or supports conservative management. The final choice always rests with the patient and treating team together.
He was standing in the corridor outside the lab, reading a printout the way people read a letter they were not expecting. One number was circled in blue pen: eGFR 38. He had felt fine that morning. He still felt fine. And yet the nurse had used the phrase “we should talk about your kidneys,” and the sentence had followed him out of the room like a draft from an open door.
Most people who hear about kidney disease treatment options for the first time arrive at that conversation the same way: blindsided by a blood test rather than a symptom. Kidneys are quiet organs. They compensate for years, then a routine panel reveals what they have been carrying.
What happens next is not one decision but a series of them, spread over months or years. This explainer walks through that sequence, from protecting the filters you still have to planning dialysis and evaluating a transplant, with the evidence for each step and the questions worth asking along the way.
Why kidney disease treatment options unfold as a sequence, not a single choice
Chronic kidney disease, usually shortened to CKD, means the kidneys have been damaged and are gradually losing their ability to filter blood, with the changes present for more than three months. That three-month rule matters. A single abnormal result after a stomach bug or a course of anti-inflammatory tablets is not CKD; a pattern that persists is (Mayo Clinic).
Because the disease moves slowly for most people, treatment is layered rather than chosen once. The first layer protects the filtering units that still work. The second treats the consequences of reduced function, such as high blood pressure, anemia, fluid buildup and bone-mineral imbalance. The third layer, kidney replacement therapy, only enters the picture if function falls to the point where the body cannot manage without help.
Each layer involves a slightly different cast. A nephrologist, the physician who specializes in kidney medicine, coordinates the plan. A renal dietitian translates lab results into what actually goes on the plate. Nurses run dialysis education and home training. Social workers help with employment, transport and the emotional weight of a long-term diagnosis. Transplant coordinators enter when evaluation begins.
Guidelines from the NHS, the CDC and NIH agree on the shape of this pathway, and they agree on something else: the person living with the disease is a member of the team, not its subject. Shared decision-making is written into every major guideline for a reason. Two people with identical lab numbers can reasonably choose different paths depending on their age, other illnesses, work, family and what they want their days to look like.
So when someone asks how renal therapies are chosen, the honest answer begins with a question in return: chosen at which point, for which person, and toward which goal?
What the stages of kidney disease mean for treatment decisions
Staging rests on two tests. The first is eGFR, the estimated glomerular filtration rate, a calculation from a blood creatinine level that estimates how much fluid the kidneys filter each minute. The second is the urine albumin-to-creatinine ratio, which measures how much protein is leaking into the urine, an early marker of filter damage.

The NHS describes five eGFR stages: stage 1 is an eGFR above 90 with other evidence of kidney damage; stage 2 is 60 to 89 with damage; stage 3 is split into 3a (45 to 59) and 3b (30 to 44); stage 4 is 15 to 29; and stage 5, sometimes called kidney failure or end-stage kidney disease, is below 15 (NHS). Higher protein leakage at any stage signals faster expected decline and a higher heart risk.
What does staging change in practice? At stages 1 and 2, the priority is the cause, most often diabetes or high blood pressure, plus annual monitoring. Stage 3 usually brings a referral to kidney specialists if protein leakage is significant or decline is fast, along with closer attention to blood pressure targets, medicines and diet. Stage 4 is when planning conversations about dialysis, transplant and conservative care formally begin, because preparation for any of these takes months. Stage 5 is when replacement therapy is either started or deliberately declined.
Two cautions keep staging honest. Trajectory matters more than the snapshot: someone stable at an eGFR of 35 for years is in a very different position from someone who dropped from 60 to 35 in eighteen months. And eGFR is an estimate, influenced by muscle mass, hydration and certain medicines, which is why teams repeat tests before changing course.
What are the early signs of kidney damage, and why tests matter more than symptoms?
The uncomfortable truth is that early kidney damage usually has no signs at all. The CDC estimates that more than 1 in 7 US adults, about 35.5 million people, have CKD, and that as many as 9 in 10 of those with the condition do not know it (CDC). Kidneys have enormous reserve. Two healthy kidneys can lose a large share of their capacity before blood chemistry drifts enough to cause anything a person would notice.
When symptoms do appear, they tend to arrive late and to be vague: tiredness that does not lift with rest, puffiness around the ankles or eyes, changes in how often urine is passed, a metallic taste, itching, or trouble concentrating. Every one of these has a dozen more common explanations, which is exactly why guidelines do not recommend waiting for symptoms.
Screening is instead tied to risk. The CDC and NHS advise regular kidney testing for people with diabetes, high blood pressure, established heart disease, a family history of kidney failure, or a history of acute kidney injury (CDC). Testing means the same two measurements used for staging: a blood test for eGFR and a urine test for albumin. Both are inexpensive to the health system, painless and widely available through primary care.
This is where the treatment story genuinely begins. The earliest and most effective intervention for kidney disease is finding it while the eGFR is still high, because the medicines and lifestyle changes described in the next sections slow decline most when there is more function left to protect. Someone whose disease is caught at stage 2 through a routine diabetes review has options that are simply narrower at stage 4.
If you carry one of the risk factors above and have not had a kidney panel with a urine albumin check, that is a reasonable thing to raise at your next appointment.
How the care team slows kidney disease: blood pressure, blood sugar and filter-protecting medicines
Three levers do most of the work in early and mid-stage CKD, and all three are aimed at the same target: lowering pressure and leakage inside the glomeruli, the tiny tufts of blood vessels where filtering happens.

Blood pressure comes first. High pressure damages glomeruli mechanically, and damaged kidneys raise pressure further, a loop that treatment interrupts. The NHS advises aiming to keep blood pressure below 140/90, or below 130/80 for people who also have diabetes, with the exact target set by the clinician (NHS). Two medicine classes are usually preferred when protein is leaking: ACE inhibitors and angiotensin receptor blockers. Both relax the blood vessel leaving each glomerulus, which drops filtration pressure and reduces protein loss. A small, expected rise in creatinine after starting them is common and monitored; the prescriber decides whether it is acceptable (Mayo Clinic).
Blood sugar control is the second lever for people with diabetes, since sustained high glucose stiffens and scars filter walls. The third is newer: SGLT2 inhibitors, a class originally developed for diabetes, which cause the kidneys to excrete more glucose and sodium and, through a feedback loop at the filter, lower internal pressure. Guidelines now describe their use in some people with CKD who do not have diabetes, based on trial evidence of slower decline (NHS, Mayo Clinic).
Around these sit supporting measures. Statins address the fact that people with CKD are far more likely to die from heart disease than to reach dialysis. Anti-inflammatory painkillers are usually avoided because they constrict kidney blood flow. As function falls, medicines to correct anemia, bind dietary phosphate or manage acid balance may be added, each addressing a specific downstream effect.
None of these is a recommendation to start or change anything. The point is to understand what each class is doing when your team suggests it, so the conversation is one between informed people.
Diet, salt and protein: what the evidence supports and what it does not
Food advice in kidney disease is where myths breed fastest, partly because the guidance changes as the disease changes. What is sensible at stage 2 can be wrong at stage 5, and vice versa.
Salt is the most consistent recommendation across stages. Sodium raises blood pressure and drives fluid retention, both of which strain kidneys and heart. The NHS advises adults with CKD to keep salt intake under 6 grams a day, roughly a teaspoon, most of which in a typical diet comes from processed food rather than the shaker (NHS).
Protein is more nuanced. Very high protein intake increases the filtering workload, so most guidelines suggest avoiding excess. Yet aggressive restriction risks muscle loss, particularly in older adults, and dialysis actually raises protein needs because the treatment removes amino acids. This is why a renal dietitian, rather than a general rule, sets the target.
Potassium and phosphate are restricted only when blood levels rise, which usually happens later in the disease. Cutting bananas, tomatoes or dairy at stage 2 on the strength of an internet list is unnecessary and can make eating well harder than it needs to be. The lab result, not the stage, drives that advice (Mayo Clinic).
Then there is the question people ask most quietly: are there home remedies for kidney function? The evidence-based answer is that no herb, tea, juice or supplement has been shown to restore kidney function, and several have been shown to harm it. Some botanical products contain compounds directly toxic to the kidney, others interact with prescribed medicines or add hidden potassium. The NHS and Mayo Clinic both advise telling your team about any supplement before taking it.
What does help at home is unglamorous: cooking more from scratch to control sodium, staying physically active, not smoking, keeping alcohol moderate and taking prescribed medicines consistently.
When do dialysis planning conversations usually start?
Earlier than most people expect, and for a practical reason: every form of kidney replacement therapy takes months to prepare for, and starting in a crisis narrows the options.
The NIH describes kidney failure as the point where the kidneys work at less than 15 percent of normal, which corresponds to stage 5 (NIH). But planning does not wait for that threshold. Most teams open the discussion when eGFR enters stage 4, below 30, or earlier if decline is steep. The conversation typically includes structured education sessions covering hemodialysis, peritoneal dialysis, transplant and conservative management, ideally with family present.
The decision to actually start dialysis is rarely made on the eGFR number alone. Clinicians weigh symptoms such as persistent nausea, loss of appetite, fluid that no longer responds to water tablets, breathlessness from lung congestion, rising potassium that threatens heart rhythm, and acid buildup in the blood. Some people with an eGFR of 8 feel well and are watched carefully; others at 14 have symptoms that make waiting unreasonable. The trend in international guidance has moved away from starting on numbers and toward starting when the body signals the need (NHS).
Preparation has concrete steps. If hemodialysis is likely, a surgeon may create an arteriovenous fistula in the arm, and that access needs time to strengthen before use. If peritoneal dialysis is chosen, a soft catheter is placed in the abdomen and given time to heal. If a transplant is possible, evaluation can begin while function remains, opening the door to a transplant before dialysis is ever needed, sometimes called a pre-emptive transplant.
People often describe this phase as the hardest emotionally, because nothing has changed in how they feel while everything has changed in what they are being asked to consider. Teams know this, and asking for a repeat conversation or a second education session is completely normal.
How does dialysis work in plain language?
A healthy kidney does several jobs at once: it removes waste products such as urea and creatinine, balances salts like potassium and sodium, removes excess water, keeps blood acidity in range and produces hormones that regulate red blood cells and bone health. Dialysis replaces some of these functions, not all of them.
The physics is simpler than the machinery suggests. Dialysis relies on a semipermeable membrane, a barrier with holes small enough to let water and small dissolved molecules pass while holding back blood cells and large proteins. On one side flows blood, on the other a carefully mixed fluid called dialysate. Waste products in the blood are highly concentrated; the dialysate contains none. Molecules naturally drift from high to low concentration across the membrane, a process called diffusion, so urea, creatinine and excess potassium move out of the blood. Meanwhile the dialysate is designed with the right amounts of sodium, calcium and bicarbonate, so those substances are restored rather than removed.
Water is handled separately. Applying gentle pressure across the membrane pushes fluid out of the blood, a process called ultrafiltration. This is how dialysis removes the extra liters that failing kidneys can no longer pass as urine.
The two main forms of dialysis differ only in where the membrane is. Hemodialysis uses an artificial membrane inside a filter cartridge, with blood pumped out of the body and back. Peritoneal dialysis uses the peritoneum, the natural lining of the abdominal cavity, as the membrane, with dialysate placed inside the abdomen through a catheter (NIH).
What dialysis cannot do is make hormones. That is why people on dialysis often still need medicines to treat anemia and protect bone, and why blood pressure, diet and fluid limits remain part of daily life. Dialysis is a treatment that sustains life; it is not a replacement kidney.
Hemodialysis: what happens in a center and what changes at home
Hemodialysis is the form most people picture: a chair, a machine, tubing carrying blood out and back. According to the NHS, in-center treatment usually means three sessions a week, each lasting about four hours (NHS). The machine pumps blood through the filter, cleans it and returns it, moving only a small volume outside the body at any moment.
Access is the practical heart of hemodialysis, because two needles must connect to a vessel with strong flow several times a week. The preferred access is an arteriovenous fistula, created by a surgeon joining an artery directly to a vein, usually in the forearm or upper arm. Over the following weeks to months the vein thickens under arterial pressure until it can tolerate repeated needling; the NHS notes this is why the fistula is usually made well before dialysis is expected to begin (NHS). Alternatives include a graft, a soft synthetic tube joining artery and vein when veins are unsuitable, and a central venous catheter placed in a large neck vein, which allows immediate use but carries higher infection risk and is generally treated as a bridge.
Side effects during or after sessions are common and mostly manageable: low blood pressure as fluid is removed, muscle cramps, headache, tiredness that can last into the evening. Teams adjust fluid removal targets and session length to reduce them.
Home hemodialysis uses the same principle with a smaller machine and training for the person and often a partner. Because it can be done more frequently or overnight, it allows gentler fluid removal and fewer dietary limits for some people. It demands space, discipline and confidence with needles. Whether it suits someone depends on their home, support and preferences, and it is usually offered after discussion rather than assumed (NIH).
Peritoneal dialysis: using the body's own lining as the filter
Peritoneal dialysis moves the treatment inside the body. A surgeon places a soft, permanent catheter through the abdominal wall so that one end sits in the peritoneal cavity and the other emerges a few inches below the navel. Dialysate flows in, dwells for a period while waste and excess water cross the peritoneal membrane into the fluid, and is then drained out and replaced. Each fill-dwell-drain cycle is called an exchange.
There are two schedules. Continuous ambulatory peritoneal dialysis, or CAPD, is done by hand during the day; the NHS describes exchanges taking about 30 to 40 minutes each, usually four times daily, with normal activity in between (NHS). Automated peritoneal dialysis, or APD, uses a bedside machine to perform exchanges overnight, typically over 8 to 10 hours while a person sleeps, leaving the day largely free (NHS).
The appeal is independence. No needles, no fixed center schedule, treatment that travels and gentler continuous removal of fluid, which some people find easier on blood pressure and energy. Many people continue working with little visible disruption.
The trade-offs are real. The catheter is a permanent opening, and peritonitis, infection of the abdominal lining, is the most significant risk; cloudy drained fluid with abdominal pain or fever needs same-day attention. The glucose used in dialysate to draw water is partly absorbed, which can affect weight and blood sugar. The fluid inside the abdomen can worsen hernias. And storage space for supplies is not trivial.
Suitability is a clinical judgment. Extensive previous abdominal surgery, certain bowel conditions or severe obesity can make peritoneal dialysis less effective, while manual dexterity and vision matter for doing exchanges safely. Over years the peritoneal membrane can lose efficiency, and some people transition to hemodialysis. None of this makes it a lesser option; it is a different one, and guidelines describe both forms as appropriate first choices depending on the person (NIH).
Dialysis vs kidney transplant: a side-by-side view
People often frame this as a contest, but the more useful way to see it is as a set of routes with different demands. The table below draws on descriptions from the NIH and NHS; it is a starting point for conversation, not a scorecard.
| Option | Where and how often | What it involves | Common considerations |
|---|---|---|---|
| In-center hemodialysis | Dialysis unit, usually three sessions a week of about four hours (NHS) | Blood filtered through an artificial membrane via fistula, graft or catheter | Fixed schedule; staff present; fluid and dietary limits; post-session fatigue common |
| Home hemodialysis | Home, often more frequent or overnight | Same principle with a home machine after training | Flexibility; needs space, training and often a partner; gentler fluid removal for some |
| Peritoneal dialysis | Home, daily exchanges by hand or overnight by machine (NHS) | Dialysate placed in the abdomen through a permanent catheter | Independence and travel-friendly; peritonitis risk; supply storage; membrane may tire over years |
| Kidney transplant | One operation, then lifelong clinic follow-up | Donor kidney placed in the lower abdomen; lifelong anti-rejection medicine | Closest to normal kidney function; requires medical suitability and a donor; medicine side effects and infection risk |
| Conservative management | Clinic and home, no dialysis | Medicines, diet and symptom control without replacement therapy | Chosen when dialysis is unlikely to add meaningful benefit or is not wanted; focus on quality of life |
A few points the table cannot hold. A transplant is not an alternative to dialysis for everyone, because it requires both a suitable recipient and an available kidney, and many people spend time on dialysis while waiting. Dialysis is also not a single permanent decision; people move between forms as health, home life and access change. And conservative management, far from being the absence of treatment, is an active plan with its own team.
The question worth asking is not which is best, but which fits this body, this household and these priorities right now, knowing the answer can change.
How transplant evaluation works, and who is usually asked to wait
A kidney transplant places a donated kidney, from a living or deceased donor, into the lower abdomen and connects it to the recipient’s blood vessels and bladder. The person’s own kidneys are usually left in place. Because the immune system recognizes the new organ as foreign, recipients take immunosuppressant medicines, which dampen immune activity, for as long as the kidney functions (NHS).
Evaluation asks two questions: can this person safely undergo major surgery and lifelong immunosuppression, and is a transplant likely to help more than it harms? Answering them involves heart assessment, because cardiovascular disease is common in kidney failure; screening for infections that immunosuppression could reactivate; age-appropriate cancer screening; blood group and tissue typing to guide matching; imaging of the blood vessels and bladder; and a frank discussion about medicine adherence, support at home and mental health. A dietitian and social worker are usually part of the process.
Some people are asked to wait rather than being declined. Common reasons include an active infection that needs treating first, a recent cancer where guidelines advise an observation interval, uncontrolled heart or lung disease that raises surgical risk, active substance use, or weight-related surgical risk that the team wants addressed. Waiting is not a judgment; it is the team reducing avoidable harm. Age alone is not a barrier in most programs, and older adults are transplanted regularly when otherwise fit.
Living donation changes the timeline. A relative, friend or altruistic stranger who passes their own thorough evaluation can donate one kidney, allowing the operation to be scheduled rather than waited for. The NHS notes that kidneys from living donors tend to function longer on average than those from deceased donors, and that a pre-emptive transplant before dialysis is sometimes possible when a living donor is available (NHS).
A transplant is a treatment, not a resolution. It trades the burden of dialysis for the burden of monitoring, medicines and their side effects. Most people who are candidates consider that trade worthwhile, but the weighing is theirs to do.
Conservative kidney management: when not choosing dialysis is a legitimate choice
There is a fourth kidney disease treatment option that education sessions sometimes rush past, and it deserves a slower look. Conservative kidney management, also called supportive care, means treating kidney failure with medicines, diet and symptom control while deliberately not starting dialysis or pursuing transplant.
The NHS describes it as a choice some people make, particularly those who are older, frail or living with several other serious conditions, where dialysis may not extend life meaningfully and its demands may reduce the quality of the time that remains (NHS). Dialysis is physically taxing. Three long sessions a week with transport, recovery time and fluid limits is a heavy load for someone already managing heart failure, dementia or advanced frailty. For such people, guidelines recognize that the question is not whether dialysis is possible but whether it is kind.
What conservative management actually involves is far from passive. Blood pressure and fluid are still treated. Anemia is corrected. Nausea, itching, restless legs and breathlessness are actively managed with medicines and practical measures. Diet is adjusted to control potassium and phosphate as function falls. A palliative care team, whose specialty is comfort and quality of life rather than only end-of-life care, is often involved early. People on conservative pathways frequently live for a considerable time with their remaining kidney function, and the plan is reviewed as things change.
Choosing this route is not the same as giving up, and it is not irreversible in the moment of choosing; some people revisit the decision. Nor should anyone feel steered toward it. The role of the team is to lay out honestly what each path is likely to mean for this particular person, in years and in days, and then to support whichever direction they take. Families often find that having the conversation early, while the person is well enough to lead it, brings more peace than any other single step.
What the following weeks usually look like once a plan is set
The period after a decision has its own rhythm, and knowing it in advance takes some of the strangeness out of it.
If hemodialysis is the plan, the first milestone is access surgery, usually a day procedure under local or regional anesthesia. The arm is kept clean and unrestricted, and people are taught to feel for the buzz of blood flow through the fistula. Over the following weeks to months the vein strengthens; the team checks its progress with examination and sometimes ultrasound before the first needles are placed (NHS). The first sessions are often shorter and gentler while the body adjusts, and fatigue after treatment is common early on.
If peritoneal dialysis is chosen, catheter placement is followed by a healing period before regular exchanges begin, then a training course, typically over one to two weeks, in which a nurse teaches the technique, hygiene and troubleshooting until the person can perform exchanges independently at home (NHS).
After a transplant, the NHS describes a hospital stay of around a week, with the new kidney sometimes starting to work immediately and sometimes taking days to weeks, during which dialysis may continue temporarily (NHS). Clinic visits are frequent in the early weeks, often several times a week, to check kidney function and adjust anti-rejection medicine, then space out over months. Wound care, infection precautions and learning a new medicine routine dominate this phase.
For those on conservative management or still at earlier stages, the following weeks look more like recalibration than transformation: a dietitian appointment, medicine adjustments, a blood pressure monitor at home, and a schedule of repeat labs to see whether the plan is holding the line.
Across every route, the people who describe the transition as manageable tend to share one habit: they ask the team what to expect at each step, and they call when something departs from it.
What people often get wrong about kidney disease treatment options
A diagnosis attracts advice the way a porch light attracts moths. Some of it is harmless. Some of it delays or derails good care. These are the misunderstandings clinicians hear most.
Stage 3 means dialysis is around the corner. It does not. Stage 3 covers a wide band of function, and many people remain there for years or for life with treatment. Progression is not inevitable, and the rate varies enormously with cause, blood pressure and protein leakage (Mayo Clinic).
Drinking large volumes of water flushes the kidneys clean. Adequate hydration matters, and dehydration can cause acute injury, but excess water does not restore lost function. In advanced disease, fluid intake often needs to be limited rather than increased, because failing kidneys cannot pass it.
Herbal cleanses and detox teas support kidney health. No such product has evidence of benefit, and some contain compounds directly toxic to kidney tissue or interact with prescribed medicines. Tell your team about anything you take.
Dialysis is a point of no return. Kidney failure from acute injury sometimes recovers, and people on chronic dialysis may go on to transplant. Dialysis also comes in several forms, and switching between them is common.
A transplant means being fixed. A transplanted kidney is a treated condition, not an absent one. It requires lifelong medicines, monitoring and infection precautions, and transplanted kidneys have a finite working life.
Older people cannot be transplanted. Age alone is not an exclusion in most programs; overall fitness is what is assessed.
Kidney disease always hurts. Most CKD is painless. Back or flank pain more often comes from muscles, stones or infection, which is exactly why blood and urine tests, not sensation, are how the disease is found.
Feeling well means the kidneys are fine. This one is the most costly. The quietness of early disease is the reason risk-based screening exists.
Questions to ask your care team
Appointments are short and the vocabulary is new, so a written list helps. These questions are drawn from what people commonly wish they had asked earlier. Not all will apply to every stage.
- What is my current eGFR and urine albumin level, and how have they changed over the past year or two?
- What do you think is causing my kidney disease, and is that cause treatable?
- Which of my medicines are protecting my kidneys, and are any of my current medicines or supplements a risk to them?
- What blood pressure target are you aiming for in my case, and how should I monitor it at home?
- Should I see a renal dietitian, and which specific foods or nutrients matter for my results right now?
- At what point would you want to start planning for dialysis or transplant, and what would prompt that conversation sooner?
- Am I a potential transplant candidate, and could I be evaluated before I need dialysis?
- If dialysis becomes necessary, which forms are realistic for my body, my home and my work, and what would each mean for my week?
- What would conservative management look like for someone in my situation?
- What symptoms or changes should make me contact you before my next appointment?
- Who on the team can I call between visits, and how?
- Are there vaccinations you recommend for me, given my kidney function?
- How will we know if the current plan is working, and when will we review it?
Bring someone with you if you can. A second set of ears catches what the first misses, and the person who will share the road with you deserves to hear the map described firsthand. Ask for a written summary of the plan before you leave; most teams are glad to provide one.
When to call your doctor: red-flag signs at every stage
Kidney disease usually changes slowly, which makes the sudden changes stand out. The following warrant a same-day call to your kidney team or, where marked, emergency care. This list is for people already under care, not a tool for diagnosing kidney disease from scratch.
Seek emergency help immediately for chest pain or pressure, severe or sudden breathlessness especially when lying flat, new confusion or extreme drowsiness, a seizure, fainting, or a very irregular or racing heartbeat. In kidney failure these can signal dangerous potassium levels, fluid in the lungs or heart strain, and they do not wait.
Contact your team the same day if urine output drops sharply or stops, swelling of the legs, face or abdomen increases quickly, weight jumps by more than your team’s stated limit between dialysis sessions, vomiting prevents you keeping medicines down, or you cannot eat or drink for more than a day.
For people with dialysis access: call promptly for redness, warmth, pus or fever around a fistula, graft or catheter site; bleeding from the access that does not stop with firm pressure after several minutes; a fistula that has lost its usual buzz or thrill; or, with peritoneal dialysis, cloudy drained fluid, abdominal pain or fever, which can indicate peritonitis and needs same-day assessment.
For transplant recipients: fever, pain or tenderness over the new kidney, a fall in urine output, sudden weight gain, or any missed doses of anti-rejection medicine should be reported the same day. Infection and rejection are both far more treatable when caught early.
At earlier stages, call if blood pressure readings at home are persistently well above your target, if you develop a new illness with vomiting or diarrhea that risks dehydration, or if any clinician prescribes a new medicine, particularly an anti-inflammatory or antibiotic, without knowing about your kidney disease.
None of these calls is a nuisance. Teams would far rather hear about a false alarm than miss a real one, and the decision about what to do next belongs to them.
Frequently asked questions
What is the life expectancy after being diagnosed with kidney disease?
There is no single number, because outlook depends on stage, rate of decline, the underlying cause, age and other conditions, especially heart disease. Many people diagnosed at stages 1 to 3 live for decades with treatment and never need dialysis. Even in kidney failure, outcomes vary widely by treatment route and overall health. Your nephrologist can discuss what the evidence suggests for your specific situation, which is far more meaningful than any population average.
What are the early signs of kidney damage?
Usually there are none, which is the central problem. Kidneys compensate for lost function for years, so early disease is found by blood and urine tests rather than by how a person feels. Late symptoms such as swelling, fatigue, changes in urination or itching are vague and have many other causes. If you have diabetes, high blood pressure, heart disease or a family history of kidney failure, regular testing is what detects damage early.
Can you recover from stage 1 kidney failure?
Stage 1 is early kidney disease with preserved filtering function, not kidney failure, and it is often stable for many years or for life. Existing scarring is generally not reversed, but treating the cause, controlling blood pressure and blood sugar and avoiding kidney-harming medicines can hold function steady and reduce protein leakage. Acute kidney injury from illness or dehydration is a different situation and can recover fully. Your team can clarify which applies to you.
What are some home remedies for kidney function?
No herb, tea, juice or supplement has been shown to restore kidney function, and several have been linked to kidney harm or dangerous interactions with prescribed medicines. What genuinely helps at home is evidence-backed and unglamorous: keeping salt intake low, cooking from scratch, staying active, not smoking, taking prescribed medicines consistently and avoiding over-the-counter anti-inflammatory painkillers. Always tell your kidney team about any supplement before starting it.
How does dialysis work?
Dialysis moves waste products and excess fluid out of the blood across a semipermeable membrane into a specially mixed fluid called dialysate, using diffusion for wastes and gentle pressure for water. In hemodialysis the membrane is an artificial filter outside the body; in peritoneal dialysis it is the natural lining of the abdomen. Dialysis replaces filtering but not the kidney’s hormone functions, so medicines for anemia and bone health often continue.
What is the difference between dialysis vs kidney transplant in daily life?
Dialysis is an ongoing treatment with a schedule, fluid and diet limits and either regular center visits or home exchanges. A transplant replaces that routine with one operation followed by lifelong anti-rejection medicines, infection precautions and clinic monitoring that is frequent at first and then spaces out. Transplant comes closest to normal kidney function but requires medical suitability and an available donor, so many people use dialysis while waiting or as their long-term choice.
Can I go straight to a transplant without dialysis?
Sometimes, yes. A pre-emptive transplant, performed before dialysis is needed, is possible when evaluation is completed while kidney function remains and a suitable donor, most often a living donor, is available. It requires early referral, usually during stage 4. Not everyone has this option, and waiting for a deceased-donor kidney often takes longer than the kidneys will last, which is why dialysis and transplant planning frequently run in parallel.
Does dialysis hurt?
The treatment itself is not painful, though needle placement for hemodialysis causes a brief sting that most people find tolerable, and numbing cream is often used. During sessions some people experience cramps, low blood pressure or headache as fluid is removed, and tiredness afterward is common. Peritoneal dialysis exchanges are painless once the catheter has healed. Discomfort that is new, severe or at an access site should always be reported to the team.
Which stages of kidney disease treatment involve a specialist?
Stages 1 and 2 are often managed in primary care with treatment of the cause and yearly monitoring. Referral to a nephrologist is commonly advised at stage 3 when protein leakage is significant or decline is fast, and routinely at stage 4, when planning for dialysis, transplant or conservative care begins. Stage 5 is managed by the kidney team. Thresholds vary by health system, so ask your clinician what applies locally.
What happens if someone decides to stop dialysis?
Stopping dialysis is a recognized choice, most often made by people who are very frail or whose other illnesses have progressed, and it shifts care toward comfort and symptom control with the kidney and palliative teams. Without dialysis, waste and fluid accumulate over days to weeks, and the team actively treats breathlessness, nausea and other symptoms. This decision should be discussed thoroughly with clinicians and family, and it can be revisited.
References
- Choosing a Treatment for Kidney Failure: NIH, National Institute of Diabetes and Digestive and Kidney Diseases
- Chronic kidney disease: Treatment: NHS
- Dialysis: NHS
- Kidney transplant: NHS
This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.
More from the Blog
After Urethritis Treatment: Follow-Up Testing and When Symptoms Are Expected to Settle
After urethritis treatment, guidelines recommend a repeat chlamydia or gonorrhea test about three months later to check for reinfection, rather than an immediate test…
Hydration After Nephrotoxicity: Why Drinking Plans Are Individualized Rather Than Fixed
After nephrotoxicity, there is no single correct amount to drink. The right fluid plan depends on how much urine the recovering kidneys are making,…
When Does Hypospadias Repair Need a Second Operation? Fistula, Narrowing and Revision
A second operation after hypospadias repair is usually needed when a fistula forms, meaning urine leaks from a small extra opening on the underside…
What Does a Cystoscopy Show? Reading a Normal Report and What Common Findings Mean
A cystoscopy shows the inside of the urethra and bladder in real time through a thin camera. A normal report describes a smooth, pale-pink…
Dialysis Access Care: Bleeding, Swelling or Fever Near the Site and When to Report It
Dialysis access site infection signs include new redness, warmth, tenderness or pus at a fistula, graft or catheter site, fever or shaking chills (especially…
Recurrent UTIs After Menopause: Why They Increase and How Treatment Is Adjusted
Recurrent UTIs become more common after menopause largely because falling estrogen thins the tissue of the vagina and urethra, reduces protective lactobacilli, and raises…






